ClinicalTrials.Veeva

Menu

Discard the Curative Causes of Late Onset Epilepsy: the Role of Brain 18F-FDG PET (EPITEP)

C

Central Hospital, Nancy, France

Status

Not yet enrolling

Conditions

Alzheimer Disease
Late Onset Epilepsy

Treatments

Diagnostic Test: TEP FDG

Study type

Observational

Funder types

Other

Identifiers

NCT05831371
2023PI065

Details and patient eligibility

About

Etiology and cognitive prognosis in late onset epilepsy differ from young adults epilepsy. At the epilepsy onset, this is crucial to detect potential curative/treatable brain disorders. After classical investigation including morphological brain imaging, EEG, clinical assessment, which added value may have brain FDG PET in the diagnosis and prognosis evaluation?

Enrollment

87 estimated patients

Sex

All

Ages

60+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • late onset épilepsy patients without lesion
  • epilepsy followed at the CHRU Nancy france

Exclusion criteria

  • epilepsy explained by cortical lesion
  • severe psychiatric disorders
  • severe addiction (alcool, drugs)
  • no FDG TEP performed
  • no neuropsychological assessement after 2 years epilepsy onset

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems